Simvastatin and Maxolon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Simvastatin (simvastatin) and Maxolon (metoclopramide hydrochloride). Common drug interactions include malignant neoplasm progression among females and dehydration among males.

The phase IV clinical study analyzes what interactions people have when they take Simvastatin and Maxolon. It is created by eHealthMe based on reports of 66 people who take the same drugs from the FDA, and is updated regularly.

What is Simvastatin?

Simvastatin has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 256,970 Simvastatin users. Check the latest studies of Simvastatin.

What is Maxolon?

Maxolon has active ingredients of metoclopramide hydrochloride. It is often used in nausea. eHealthMe is studying from 1,977 Maxolon users. Check the latest studies of Maxolon.



On Aug, 06, 2026

66 people who take Simvastatin and Maxolon together, and have interactions are studied.

Simvastatin and Maxolon drug interactions.

What are the common drug interactions of Simvastatin and Maxolon, by gender? *:

female:

  1. Malignant neoplasm progression (cancer tumour came back)
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Renal failure acute (rapid kidney dysfunction)
  4. Renal failure chronic (long lasting kidney dysfunction)
  5. Skin discolouration (change of skin colour)
  6. Thrombocytopenia (decrease of platelets in blood)
  7. Metastases to lung (cancer spreads to lung)
  8. Respiratory failure (inadequate gas exchange by the respiratory system)
  9. Abdominal pain upper
  10. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)

male:

  1. Dehydration (dryness resulting from the removal of water)
  2. Diarrhoea
  3. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  4. Fall
  5. Neutropenia (an abnormally low number of neutrophils)
  6. Pulmonary haemorrhage (acute bleeding from the lung)
  7. Fatigue (feeling of tiredness)
  8. Narcolepsy (brain's inability to regulate sleep-wake cycles normally)
  9. Cardiac disorder
  10. Chest pain

What are the common drug interactions of Simvastatin and Maxolon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Death

40-49:

  1. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Migraine (headache)
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

50-59:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
  3. Dehydration (dryness resulting from the removal of water)
  4. Diarrhoea
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Haematemesis (vomiting of blood)
  7. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)

60+:

  1. Dehydration (dryness resulting from the removal of water)
  2. Renal impairment (severely reduced kidney function)
  3. Neutropenia (an abnormally low number of neutrophils)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Acute myocardial infarction (acute heart attack)
  6. Anaemia (lack of blood)
  7. Asthenia (weakness)
  8. Atrioventricular block first degree (heart block first degree)
  9. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  10. Decreased appetite

What are the existing conditions these people have? *

  1. High Blood Pressure: 13 people, 19.70%
  2. Nausea And Vomiting: 10 people, 15.15%
  3. Diabetes: 10 people, 15.15%
  4. Hyperlipidaemia (presence of excess lipids in the blood): 7 people, 10.61%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 10.61%
  6. Constipation: 7 people, 10.61%
  7. Insomnia (sleeplessness): 6 people, 9.09%
  8. Indigestion: 6 people, 9.09%
  9. Flatulence (flatus expelled through the anus): 6 people, 9.09%
  10. Dyspnea (difficult or laboured breathing): 6 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Simvastatin and Maxolon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Simvastatin and Maxolon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Simvastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Maxolon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Simvastatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Maxolon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on simvastatin and metoclopramide hydrochloride (the active ingredients of Simvastatin and Maxolon, respectively), and Simvastatin and Maxolon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: